Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Sepsis a Significant factor in Covid-19 Deaths
View:
Post by mercedesman on Dec 20, 2021 5:07pm

Sepsis a Significant factor in Covid-19 Deaths

We often refer to COVID-19 as the novel coronavirus.  That’s because this virus – SARS-CoV-2 – is a new type of coronavirus affecting humans.  But now, a new report says that there is nothing novel, or new, about what is killing a lot of COVID-19 patients – Sepsis.

https://www.medmalfirm.com/news-and-updates/sepsis-factor-covid-19-deaths/
Comment by hmmmmmmmm on Dec 20, 2021 6:49pm
“The best COVID-19 care includes good sepsis care.” This is a good find. I too can not understand why we have abandoned any PMX/ COVID-19 testing. After 20 months of barely any Tigris patients- you'd think we would have had the time/ staff/ interest to have pursued this. I have a faint memory of a University doing a PMX/ COVID trial in the US.. anyone else remember this or have any info I ...more  
Comment by Domino55 on Dec 20, 2021 7:33pm
For whatever reason they were explicit in saying there was little to no room to discuss Covid, even suggesting it was a passing phenomenon. Unless it's another in a long line of "bluffs" there doesn't appear to be much time for studying or reporting on PMX and Covid.
Comment by mercedesman on Dec 20, 2021 9:48pm
What would possess a Co., that has, by all accounts,  at least a partial solution to, arguably, the world's biggest problem right now, to shelve any efforts to study the problem ( or even talk about it in more detail), ...all while apparently sidelined by that very problem for almost two years? Anyone else see the excruciating irony?  MM 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities